220 likes | 322 Vues
Learn about juvenile systemic lupus erythematosus (SLE) diagnosis, symptoms, lab tests, and treatment. Prognosis and survival rates for pediatric patients. SLE manifestations vary across different ethnic groups. Multigenic clinical features impact disease severity.
E N D
September 24, 2010 Morning Report
SLE • 20% diagnosed in childhood • Mostly in adolescence • F:M ratio • Prior to puberty - 3:1 • After puberty - 9:1 • Native Americans > African Americans > Hispanics > Chinese > Filipinos • More severe disease in AA and Hispanics • Multigenic
Clinical Manifestations • Most common symptoms in teenagers • Fever • Rash • Mucositis • Arthritis • Constitutional • Weight loss • Malaise
Mucocutaneous • Butterfly rash • Malarerythema • Photosensitive • Sparing of nasolabial folds • Discoid lesions • Scalp or extremities • Photosensitive • Maculopapular lesions • Occur anywhere
Mucocutaneous • Alopecia • Begins frontal • Spreads diffusely • Rarely permanent • Vasculitic • Palmarerythema • Mucosal lesions • Ulcers • Sometimes painless
CNS • 2nd leading cause of morbidity and mortality • Psychiatric • Psychosis • Seizures • HA • Lupus cerebritis • Also difficulty with concentration, memory, depression or decline in school performance • Less commonly • Chorea, neuropathies, transverse myelitis
Cardiovascular • Any layer of the heart affected • Pericardium • Most common • Myocarditis • CHF, arrhythmia • Libman-Sacks endocarditis • At risk for SBE
Cardiovascular • Raynaud phenomenon • Very common in adolescents • Cold, emotional stress, caffeine, cigarette smoke • At risk for infarction • Premature atherosclerosis
Pulmonary • Pleuropulmonary disease • Pleuritic chest pain • Effusion • 60% of adolescent patients will have abnormal PFTs • Other • Pneumonitis • Pulmonary Hemorrhage • Pulmonary HTN
Gastrointestinal • Abdominal pain is common • Pancreatitis • Mesenteric vasculitis • Peritonitis • Hepatitis • Question #2
Renal • #1 cause of morbidity • 75% of children within first 2 years • Signs • Microscopic hematuriaand proteinuria • HTN • Decreased GFR • Elevated BUN or Cr
Renal • Renal Biopsy
Musculoskeltal • Arthralgia • Arthritis • Nonerosive, nondeforming • Small and large joints • Myalgia • Proximal muscle weakness • Myositis • Possible MCTD
Hematologic • Cytopenia • Any cell line • Anemia 50% • Normocyticnormochromic • Anemia of chronic disease or autoimmune hemolytic • ITP
Lab Eval • ANA • Best screening test • Positive in almost all that have active disease • Not specific • More specific if ≥ 1:1,280 • Other diseases • JIA, Dermatomyositis, scleroderma, thyroid disease
Lab Eval • Complement (C3, C4) • Reduced levels • May indicate need for aggressive therapy
Lab Eval • Antiphospholipid antibodies • CBC • Electrolytes • BUN and Cr • Hepatic Enzymes • Acute-phase reactants • UA
Treatment • Consult with Rhematology • Treatment depends on clinical manifestations • Emerging morbidity is associated with treatment • Close monitoring
Prognosis • Improving • Juvenile-onset • 92% - 5 year survival rate • 85% - 10 year survival rate • Major causes of death • Renal disease • Infection • CNS disease